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Environmental health risk assessment
contributes increasingly to policy develop-
ment, public health decision making, the
establishment of environmental regulations,
and research planning. It also often plays an
important role in cost–beneﬁt analysis and
risk communication. Its credibility depends,
to a large extent, on the strength of the sci-
entific evidence on which it is based.
Epidemiology, toxicology, clinical medicine,
and environmental exposure assessment all
contribute information for risk assessment.
However, epidemiological studies play a
unique role in the assessment of the health
risk of environmental factors. Unlike labora-
tory experiments, epidemiology provides evi-
dence based on studies of human populations
under real-world conditions. It largely avoids
the extrapolations across species and levels of
exposure required for the use of data from
animal experiments, which contribute large
uncertainties. In addition, epidemiology has
often contributed to the recognition of new
hazards, thereby stimulating new research
and identifying new areas for public health
action. The contribution of epidemiology  to
health risk assessment has been widely dis-
cussed (1–5). However, epidemiological
studies that report associations between mea-
sures of the health of populations and the
presence of hazardous factors in the environ-
ment are frequently difficult to interpret
(6,7). Therefore, a careful evaluation of all
existing epidemiological evidence is necessary
as part of the risk assessment process.
To provide authoritative assessments of
environmental epidemiology research, pub-
lic health and regulatory agencies may rely
on expert review groups to evaluate the evi-
dence, draw conclusions on the existence of
hazard to health, and estimate the magni-
tude of associated health risks. These expert
reviews may then be used to support
actions that are difficult and expensive. It
is, therefore, imperative that the processes
and methods used to evaluate the evidence
and estimate health risks are clear, explicit,
and based on valid epidemiological theory
and practice.
To improve the methodology used by the
expert groups reviewing the evidence, the
World Health Organization (WHO)
European Centre for Environment and
Health, Bilthoven Division, in collaboration
with the International Programme on
Chemical Safety, initiated the project
“Accepting Epidemiological Evidence for
Health Impact Assessment.” The results of this
project are presented in this paper. This
report, together with the “Appendix,” summa-
rizing the discussion of the working subgroups
is also available as a WHO document (8).
Scope and Purpose
The purpose of this project is to develop
guidelines that identify a set of processes and
general approaches to assess available
epidemiological information in a clear,
consistent, and explicit manner. The guide-
lines should also help in the evaluation of
epidemiological studies with respect to their
ability to support risk assessment and, conse-
quently, risk management.
Conducting expert reviews according
to such explicit guidelines would make
health risk assessment and subsequent risk
management and risk communication
processes more readily understood and
likely to be accepted by policymakers and
the public. From the standpoint of WHO,
it would also make the conclusions reached
by reviews more readily acceptable as a
basis for future WHO guidelines and other
recommendations, and would provide a
more rational basis for setting priorities for
future research.
This project focuses only on approaches
to the evaluation and use of epidemiological
evidence for health risk assessment.
However, this should not be interpreted as
implying that only epidemiological studies
are important. The working group, and
WHO, appreciate that data from toxicologi-
cal, clinical, and other areas of research often
play vital roles in both the characterization
of health hazards and the estimation of risks
to health, and may, in the absence of suitable
epidemiological data, provide the sole basis
for such activities.
Public health action (e.g., the reduction
of population exposure to a suspected haz-
ard or even its elimination from the human
environment) must often proceed even
when the scientiﬁc evidence is insufﬁcient.
Most of the working group members agree
that the precautionary principle should play
a role in guiding public health action where
there is uncertainty. 
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Workshop SummaryThe project considers two distinct activi-
ties of health risk assessment: health hazard
characterization and health impact assess-
ment. They correspond to components of
risk assessment defined by both the U.S.
National Research Council (NRC) and
WHO (1,9). 
• Health hazard characterization involves the
identiﬁcation of environmental hazards via
the collection, evaluation, and interpretation
of available evidence from epidemiology and
other scientiﬁc disciplines concerning the
association between an environmental factor
and human health.
• Health impact assessment involves the
quantiﬁcation of the expected health bur-
den due to an environmental exposure in a
speciﬁc population.
Health hazard characterization comprises
the hazard identiﬁcation and elements of the
dose–response assessment stages of the NRC
risk assessment paradigm, at least as they
apply to epidemiological studies. Health
impact assessment combines the exposure
assessment, dose–response assessment, and
risk characterization stages of the NRC and
WHO risk assessment paradigm. Thus, the
two stages overlap and interlock.
This project focuses on the evaluation
and use of epidemiological evidence on asso-
ciations between environmental factors and
health. This evidence is used to support the
assessment of health impact of certain
exposures. The health impact assessment
discussed in this report is, therefore, not syn-
onymous with the broader concept of assess-
ment of health impacts of speciﬁed action on
the health of a deﬁned population. The lat-
ter is an emerging tool in the evidence-based
public health policy making. It can be
applied to a wide range of actions, policies,
or projects on various determinants of
health, such as behavioral factors, socio-
economic issues, or health care system
reforms. Environmental health risk assess-
ment, with its well-established methodology,
is a significant contribution to the wider
concept of health impact assessment (10). 
The scope and purpose of the project
with respect to the audience and the issues
that it would address have been further
reﬁned as follows:
• The target audiences for these guidelines
are expert review groups that WHO (or
other organizations) might convene in the
future to evaluate epidemiological evidence
on the health effects of environmental
factors.
• The working group convened to develop
this project saw its role as providing future
review groups with general recommenda-
tions and principles for conducting such
evaluations, rather than providing formu-
lae, or lists of approved methods.
• The working group focused on the evalua-
tion of evidence in the context of large-scale
public health issues, as opposed to local
emergencies. The working group acknowl-
edged that epidemiological studies of local
environmental exposures (e.g., clusters of
childhood leukemia in the vicinity of
nuclear power plants) might provide evi-
dence about large-scale public health con-
cerns, but felt that the evaluation of such
outbreaks presents a unique set of problems
that warrant attention in their own right.
• The working group agreed that health
impact assessments are conducted for a
range of purposes and under a variety of
conditions, and therefore the purpose of
the health impact assessment will, and
should, determine its scope, form, and
content.
• The principles described apply, in the ﬁrst
place, to chemical pollutants. In reviews
concerning some other exposures, adjust-
ments may be proposed. Should such
deviations from the principles be applied, a
clear justiﬁcation must be given.
Process
The WHO working group of experts in epi-
demiology, public health, and environmen-
tal policy was assembled at the end of 1998
(see “Appendix”). The experts were selected
on the basis of their following qualiﬁcations:
• experience in the scientiﬁc review of epi-
demiological evidence for governmental
bodies, WHO, or other public and private
sector organizations
• involvement in risk assessment of environ-
mental factors
• involvement in communication related to
health risk with general public or decision
makers
• representation of wide range of countries
within the European region of WHO and
the United States.
The experts were asked to prepare work-
ing papers presenting their views and pro-
posals concerning the process of review of
epidemiological evidence, as well as criteria
for its acceptance and use in assessment of
health risk of environmental factors. The
papers were distributed to all working group
members and provided a basis for the discus-
sion at the meeting of the working group
convened in Il Ciocco, Italy, from 31 May
to 2 June 1999. Dr. Robert Maynard
chaired the meeting, and Dr. Aaron Cohen
acted as its rapporteur. The working papers
are not included in this report, although the
individual authors may choose to publish
them elsewhere.
After a half-day plenary discussion to
establish the exact scope of the meeting and
the methods of working, two subworking
groups were formed: one to consider health
hazard characterization and another to con-
sider health impact assessment. A third
group met initially to discuss issues related to
the broader social and public policy contexts
in which environmental health risk assess-
ment is used. Their views were ultimately
incorporated into the chapters of the two
main subworking groups.
After an iterative process of subgroup
discussion and plenary meetings, the sub-
working groups summarized their discus-
sions and drafted recommendations on their
respective topics, which were further reﬁned
following the plenary meeting of the work-
ing group. These discussions are summarized
in two papers prepared by the two working
groups and are presented in Annex 3 of the
WHO document (8). On the basis of these
materials, the rapporteur of the meeting,
assisted by the chairmen and rapporteurs of
the subgroups, and the secretariat prepared a
draft of the meeting report. Prior to its ﬁnal-
ization, that draft was presented to all mem-
bers of the working group to ensure that it
correctly reﬂected the working group’s con-
sensus on the recommendations and the
rationale for them.
The draft report was discussed at a spe-
cial WHO symposium, organized at the
joint conference of the International Society
for Environmental Epidemiology and the
International Society of Exposure Analysis
in Athens, Greece, in September 1999, and
made available through the World Wide
Web for review. The comments received
from approximately 20 scientists were used
in the preparation of the ﬁnal draft of this
guideline report in November 1999.
Revisions based on these comments have
focused on improving the depth and clarity
of presentation of the recommendations and
conclusions, rather than on additional
detailed discussion of methodological issues
of risk assessment. The draft was reviewed
by the chairs and rapporteurs of the work-
ing group (and subgroups) and accepted,
with small editorial changes, as the WHO
guideline document in January 2000 (8).
Conclusions and
Recommendations 
The following text lists the major recom-
mendations made by the working group for
the evaluation and use of environmental
epidemiology studies for health risk assess-
ment. They constitute the core of the WHO
Guidelines on Epidemiological Evidence for
Environmental Health Risk Assessment (8).
The guidelines comprise a set of general
recommendations, followed by specific
recommendations for evaluations of epi-
demiological research for health hazard
characterization, and use of epidemiological
data for health impact assessment.
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Expert review groups should adopt a system-
atic and explicit approach to the assessment
of epidemiological evidence for health risk
assessment. The working group acknowl-
edged that various expert review groups had,
in the past, used a variety of methods and
standards to assess epidemiological evidence,
and that these were often inadequately
described.
Expert review groups, and the agencies
that sponsor them, should strive for better
communication with stakeholders (e.g., citi-
zens, private interests, government agencies)
regarding the process of evaluating, and
drawing conclusions from, epidemiological
evidence. The need for an evaluation of the
epidemiological evidence often reflects the
existence of divergent views among stake-
holders about the true extent of the risk.
When expert review groups make explicit
and explain in clear terms the methods they
use to conduct their evaluations and reach
their conclusions, they reduce the potential
for those conclusions to be misunderstood
and mistrusted by stakeholders.
To improve the applicability of epidemi-
ological research to health risk assessment,
future epidemiological studies should seek
where possible to provide results in a way
that enhances the health risk assessment at
the interface of epidemiology, other ﬁelds of
research, and policymaking. In particular,
the study reports should describe as precisely
as possible the exposure characteristics and
the shape of the exposure–response function,
as well as distinguish between the acute and
chronic effects of exposure.
The WHO secretariat of the future
reviews should assess the feasibility of imple-
mentation of these recommendations and
the increased time and effort that will be
needed, and modify the guidelines as neces-
sary. WHO should also attempt to assess
whether their use leads to increased accep-
tance by stakeholders of the evaluations of
environmental epidemiology research pro-
duced by expert review groups.
This proposed more rigorous and thor-
ough approach to the review of the evi-
dence and its use in health impact assess-
ment may require increased effort and
resources. The transparency of the methods
should, however, lead to a wider acceptance
and applicability of the reviews, and may
reduce the need for duplication of effort
and facilitate updating.
The working group did not propose a
scale or rating of the evidence with respect to
a level of proof required to support risk
management decisions. Although health haz-
ard characterization precedes, and is often
viewed as a prerequisite for, health impact
assessments (because it provides the scientiﬁc
justiﬁcation for them, and provides data for
the calculation of risk estimates), the exis-
tence of a speciﬁc level of scientiﬁc evidence
required to justify either a health impact
assessment or subsequent action is contro-
versial. For example, expert judgment that
the available evidence is consistent with a
causal relationship between exposure and
health effect is considered a necessary condi-
tion for action by some, but not all (11).
While most members of the working group
agreed that the precautionary principle
should play a role in public health decision-
making when there are scientiﬁc uncertain-
ties, there was no general agreement that the
principle should play a role in the evaluation
of epidemiological evidence per se.
Discussion of the level of evidence on hazard
needed to conduct health impact assessment
is summarized in section A3.1 of the WHO
guideline document (8).
Recommendations for the
Evaluation of Epidemiological
Evidence for Health Hazard
Characterization
The working group recommended ﬁve gen-
eral guidelines for ﬁve aspects of the evalua-
tion of epidemiological research:
Development of a protocol for the review.
Expert assessments of epidemiological evi-
dence for health hazard characterization
should be conducted systematically accord-
ing to an explicit protocol defined in
advance. The objectives of a systematic
review are transparency, avoidance of bias,
validity, replicability, and comprehensive-
ness. A systematic approach provides an efﬁ-
cient way of updating the evidence base as
new studies emerge, and will facilitate
research planning. A protocol for the system-
atic review ensures that the expert group has
a common understanding of its task and will
adhere to the systematic approach recom-
mended by WHO. It is expected that revi-
sions of the protocol may be needed as new
aspects of the task emerge during the review.
The essential components of the protocol
will be the following:
• Specification of the question(s) to be
addressed by the health hazard characteri-
zation.
• Justiﬁcation of the expertise represented in
the health hazard characterization expert
group. The criteria for selection should be
based on having the appropriate mix of sci-
entific expertise and experience. Within
these criteria, WHO will also consider the
need for geographic representation.
• Speciﬁcation of the methods to be used for
identification of relevant studies, assess-
ment of evidence of the individual studies,
and interpretation of the entire body of
available evidence (see below).
Identification of relevant studies. The
assessment should be based on comprehensive
identiﬁcation of all relevant studies. A com-
prehensive bibliographic search would include
the following: a) involvement of qualified
searchers (e.g., librarians, trained investiga-
tors); b) deﬁnition of an explicit search strate-
gy including identiﬁcation of key words; c) an
effort to include all available studies; d) search
of bibliographic databases; e) inclusion of
non-English reports.
Optional methods that might be consid-
ered by the expert group include hand
searching of journals, and inclusion of
abstracts and unpublished data (including
writing to authors of published data).
Systematic assessment of the validity of
epidemiological studies. As Hill emphasized
(12), this assessment should aim at answer-
ing the question, “Is there any other way of
explaining the set of facts before us [study
results], is there any other answer equally, or
more, likely than cause and effect?” The
evaluation should consider the following:
• Evidence on strength of association, its
temporality, biological plausibility, coher-
ence, consistency and speciﬁcity.
• Characteristics of exposure–response rela-
tionships. The demonstration of specific
patterns of association can provide strong
support for causal interpretations if patho-
physiological models agree with them. In
such cases, more complex, and hence less
implausible, patterns of confounding or
bias are required as counter-explanations.
In addition, the information on exposure–
response relationships in particular study
populations is an important component in
health impact assessments of other popula-
tions (see “Recommendations for the Use
of Epidemiological Data for Health Impact
Assessment”).
• Alternative explanations for the observed
associations. They fall into three categories:
chance, bias (information, selection, ana-
lytic), and confounding.
• Results of any sensitivity analysis. In such
analysis the outcome variable(s) are exam-
ined with respect to a) changes in expres-
sion of exposure variables, b) addition of
other plausible explanatory variables,
and/or c) introduction or removal of con-
founding variables.
Conduct of systematic overviews of
evidence from multiple studies: use of meta-
analysis. Although meta-analysis is widely
viewed as simply a method for statistically
combining the results of multiple studies, it
can contribute more to hazard characteriza-
tion when viewed as a quantitative review of
the literature, a “study of studies.” Conducted
in this way, a meta-analysis looks for consis-
tent patterns among, and sources of discrep-
ancies between, studies (13,14). Expert
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tions when conducting meta-analyses: a)
How will heterogeneity among studies be
assessed? b) Will summary effect estimates be
calculated, and by which methods? The work-
ing group recommends that expert review
groups consider the following issues when
designing and conducting quantitative
reviews (meta-analyses) of epidemiological lit-
erature or assessing their ﬁndings:
Protocol. Each meta-analysis must have
its own protocol, perhaps nested within the
overall protocol for the health hazard charac-
terization. The protocol should include a
clear statement of the objectives of the
review and the methods to be employed.
Inclusion criteria. It is desirable for a
meta-analysis to be inclusive rather than
exclusive. Sensitivity to various inclusion cri-
teria can then be examined. 
Use of quality scores. Reducing the fea-
tures of a set of epidemiological studies to a
single measure of quality is not recommend-
ed, because these features may affect the
results of the studies in different directions
and to varying degrees. It is preferable to
assess the characteristics of the primary studies
individually.
Chance. In meta-analysis, the results are
usually weighted by the statistical precision
(in general, by the amount of information)
of each primary study. Adjustment for the
amount of information can be achieved
through either inverse-variance weighting or
random effects models.
Publication bias. The results of certain
kinds of primary studies are more likely to
be published than of the others. The
impact of the publication bias can be mini-
mized by thorough search and inquiries
regarding completed studies. If the number
of studies in the analysis is sufﬁcient, their
results can be plotted in a funnel graph to
check for a possible publication bias.
Corrections and tests for publication bias
have been proposed, but these must be
applied with special caution because of the
assumptions involved and low power of the
tests. The impact of the publication bias
can, and should, also be assessed by sensi-
tivity analysis.
Assessment of overall heterogeneity.
Systematic, quantitative assessment of hetero-
geneity may contribute significantly to the
identification of both methodological and
natural sources of variability of epidemiologi-
cal effect estimates, including the identiﬁca-
tion of susceptible subgroups and exposure
conditions.
Meta-analytic methods that may be
used to compare studies. An example is
stratiﬁed analysis or meta-regression.
Sensitivity analyses. Such analyses
might, for example, examine the sensitivity
of summary estimates to reasonable alterna-
tives with regard to the inclusion and exclu-
sion of particular studies. One can also
evaluate the sensitivity to alternative
approaches to the extraction of results from
published reports.
Methods to obtain summary estimates
from different studies (aggregative meta-
analysis). Though quantitative summary
estimates are not essential for health hazard
characterization, they will be a particularly
useful input to the health impact assessment
(see “Recommendations for the Use of
Epidemiologic Data for Health Impact
Assessment”).
Drawing conclusions from epidemiologi-
cal evidence. After the epidemiological evi-
dence has been evaluated and appropriately
summarized, as discussed above, expert
judgment as to whether the observed associ-
ations are most consistent with a causal
explanation or some alternative is required.
This judgment should draw upon all the
available epidemiological evidence, as well as
on evidence from toxicology, clinical medi-
cine, and other disciplines, as appropriate.
The method of choice is critical scientific
thinking: there are no formulas or checklists
that will suffice, although, as noted above,
Hill’s attributes can provide useful guidance
and focus. It is critical, however, that expert
review groups make explicit the process of
scientific reasoning that led to a judgment
concerning causality. This explanation
should include  descriptions of a) how
expert reviewers weighted particular features
of the epidemiological studies (e.g., assess-
ments of bias, confounding, exposure–
response) in reaching their judgment; b)
how expert reviewers used guidelines such as
Hill’s attributes; and c) how nonepidemio-
logical sources of evidence figured in their
interpretation of the epidemiological evi-
dence, and how that evidence contributed
to their overall judgment.
Expert judgments concerning the causal
nature of observed associations are often
accompanied by qualifications as to the
degree of uncertainty. When the product of
a health hazard characterization is presented
as a conclusion regarding the existence (or
nonexistence) of a hazard, the degree of
uncertainty is sometimes expressed on a
qualitative (weak, moderate, strong evidence
for hazard) or on a quantitative scale. If a
quantitative scale is devised, it should be
capable of being reproduced by other
experts. In either case, the use of a particular
scale and the meaning of its levels should be
clearly explained. More generally, it may be
useful in the future to standardize such scales
to avoid problems of noncomparability
among the reviews produced by different
expert review groups.
Recommendations for Use of
Epidemiological Data for Health
Impact Assessment
The working group made recommendations
with regard to the use of epidemiological
data for the design, implementation, and the
interpretation of health impact assessments:
The design and implementation of health
impact assessments. Health impact assess-
ments, which aim to quantify the expected
health burden in a specific population(s)
should be conducted according to explicit
protocols that accomplish the following:
Specify the purpose of the assessment. The
purpose(s) of the health impact assessment
should be made clear, because decisions con-
cerning the choice of epidemiological and
other data and quantitative methods will
depend on the objectives of the assessment.
Ideally policymakers, scientists, and stake-
holders should be involved in defining the
scope of the assessment, as different parties
may have different questions about, and per-
spectives of, the same environmental health
issue.
Specify the method(s) used to quantify
uncertainty. It should be made explicit in
each health impact assessment what the
uncertainties are likely to be and how the
assessors will deal with them. The choice of
data and methods by which to quantify
uncertainty may be determined by the spe-
cific objectives of the impact assessment
(e.g., identiﬁcation of a maximum or mini-
mum potential impact). The quantiﬁcation
of the uncertainty contributed by epidemio-
logical effect estimates should consider both
their statistical variability (i.e., precision),
and nonstatistical variability resulting from
sources of error (e.g., bias and confounding)
in the epidemiological data.
Specify the metric of exposure to the
speciﬁed hazards and methods to identify its 
distribution in the population for which
assessment is requested. A clear and explicit
deﬁnition of the metric of exposure, i.e., the
operationalization of the cause considered in
the health impact assessment, should be
provided. Health impact assessment will
require information on the distribution of
exposure in the target population, which
will ultimately need to be combined with
information on the exposure–response func-
tion in order to conduct the assessment.
Depending on the available evidence (e.g.,
from epidemiological studies), the metric
may need to incorporate temporal (e.g.,
induction period or latency) and composi-
tional (e.g., mixtures and surrogates for
them) aspects of exposure. The impact
assessment should describe and, whenever
possible, quantify the uncertainty con-
tributed by the exposure assessment.
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will depend strongly on the level and range
of exposure used in the health impact assess-
ment. The choice of a reference level for the
impact assessment may be particularly com-
plicated and may require the consideration
of epidemiological and other data with
regard to issues such as the existence of
thresholds and natural background levels. If
exposures in the target populations exceed or
are below those that have been studied epi-
demiologically, it will be necessary to deter-
mine whether effects should be extrapolated.
Ultimately, these choices will depend on
both expert judgment and the perspective
and purpose(s) of the assessment, but the
basis for those choices should be clearly
explained.
Deﬁne the appropriate health outcomes.
A particular health impact assessment might
focus on one or several health effects. If there
is evidence of an environmental hazard being
associated with several health effects, then
ideally the impact should be assessed sepa-
rately for each one. In practice, several
aspects of the health impact assessment,
mainly its purpose and objectives, the deﬁni-
tion of exposure, and the availability of the
necessary data, will guide the selection of
health outcome(s). On the basis of these
considerations, assessors may decide not to
include all conceivable outcomes. These
decisions and their rationales should be
made explicit.
Specify methods for estimating the
exposure–response relationship. The quan-
titative association between the exposure
and the health effect(s) is an essential com-
ponent for the calculation of the attribut-
able number of cases, and information
about the exposure–response function is
potentially the key contribution of epidemi-
ological demiological studies to a health
impact assessment.
Due to both uncertainties in epidemio-
logical studies and true variability in the
association between exposure and health
outcomes within and among human popula-
tions, the available body of epidemiological
evidence may provide different exposure–
response functions for the same general
exposure–outcome relationship. Thus, for a
given health impact assessment, the process
used to derive the exposure–response func-
tion(s) must be well deﬁned. It should, at a
minimum, include a systematic review of the
available epidemiological information to
obtain information on exposure–response
relationships for every selected health out-
come. All studies with quantitative informa-
tion on exposure or that allow linkage to
such information should be considered as
potentially providing information for the
exposure–response evaluation. The hazard
characterization process normally will pro-
vide an inventory of the relevant studies.
Epidemiological studies identified as
potentially providing useful exposure-
response information may need to undergo
an additional selection process that consid-
ers: a) the quality of exposure measurement;
b) whether the exposure metric is the same
as that available for the target population of
the impact assessment; and c) whether the
estimated measures of effect are generalizable
to the target population due to the inﬂuence
of effect modifiers such as local socioeco-
nomic factors or the prevalence of suscepti-
ble subgroups.
Projecting exposure–response relation-
ships beyond the range of exposure observed
in the available epidemiological studies may
be necessary for a given health impact assess-
ment. However, the validity of such extrapo-
lations should not be simply assumed, but
rather, arguments for, and the limitations
and potential impacts of, extrapolations
should be carefully addressed in the health
impact assessment, including allowance for
additional uncertainty.
An expert group may decide that com-
bining exposure–response information from
different epidemiological studies, for exam-
ple, via meta-analysis of published results or
pooling of original data, is the best approach
for deriving an exposure–response relation-
ship for a given impact assessment. These
approaches can potentially provide not only
an overall summary of an exposure–response
function, but also (and perhaps as or more
important) a range of estimates correspond-
ing to possible sources of heterogeneity in the
target population. Care should be taken to
present estimates of the statistical and other
sources of uncertainty in any combined esti-
mates of the dose–response function.
Specify approach for obtaining measures
of baseline frequency of health outcomes in
the target population. Estimating the impact
of exposure requires information on the
baseline occurrence (rate, prevalence) of out-
come(s) in the target population. Combined
with the estimates of relative effect most
often provided by epidemiological studies, it
yields an estimate of impact of exposure in
absolute terms, e.g., number of cases of dis-
ease or deaths (see below). Although expo-
sure–response relationships may be derived
from the international literature, the baseline
disease occurrence should preferably be
obtained from data regarding the target pop-
ulation of the assessment. If such data are
unavailable or inadequate, health frequency
data from other populations may sometimes
be used. In such cases, the potential limita-
tions of such substitutions should be consid-
ered and thoroughly discussed in the health
impact assessment.
Specify methods for estimating the num-
ber of attributable cases. The estimation of
the burden of disease or mortality expected
in the target population requires three basic
elements whose estimation is discussed
above: a) the distribution of the exposure in
the target population; b) estimates of the
epidemiology-based exposure–effect func-
tion; and c) epidemiology-based estimates of
baseline frequency of the health measure of
interest.
Using this information, and under the
assumption that exposure causes the health
outcome, an epidemiology-based health
impact assessment estimates the popula-
tion-attributable proportion (of disease or
death) due to exposure, a measure described
in standard epidemiological texts (13).
When applied to the target population, the
population-attributable proportion yields
an estimate of the expected number of cases
attributed to the exposure.
In practice, both the estimation and
interpretation of the population-attributable
proportion and its application to the target
population may involve a number of sub-
tleties. These involve, for example, the
choice of relative risk estimator when there is
evidence of confounding (15,16). The
assumptions underlying the statistical meth-
ods used to estimate attributable proportions
or other measures of impact, and their impli-
cations for interpretation of those estimates,
should be discussed.
The uncertainties in the data that con-
tribute to the impact assessment, as well as
any natural sources of heterogeneity in the
effect of exposure, will often require the cal-
culation of a range of estimates in order to
describe fully the likely impact of exposure
and to better reﬂect the uncertainty.
Issues in the interpretation of health
impact assessments. The results of the impact
assessment require not only clear presenta-
tion, but also coherent interpretation,
including explicit discussion of assumptions
and limitations. Speciﬁc components of the
overall uncertainty and their potential
impact on the results should be addressed, as
discussed above. Sensitivity analyses, in
which the effects of key assumptions are
explored quantitatively, may provide a better
sense of the overall uncertainty of the esti-
mates than purely qualitative discussion, and
should be performed when appropriate.
In general, the direct effect of the
removal of a particular exposure may only
rarely be estimated. Depending on the health
outcome, the speciﬁcity of the exposure, and
the time frame of exposure and effect, the
benefit (or reversibility) may be realized
either much later than predicted, or not to
the full extent. In particular, removal of the
environmental hazard may not prevent the
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due to how competing risks may come into
play if one contributing cause (the exposure)
is removed or reduced.
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